1 / 15

Late Effects of Cancer Treatment: Endocrine Effects

Late Effects of Cancer Treatment: Endocrine Effects. Thyroid Dysfunction Adrenal Insufficiency Gonadal Toxicity Growth Hormone Deficiency. Objectives . The learner will be able to: Describe the pathophysiology of endocrine dysfunction in patients due to cancer treatment.

clovis
Télécharger la présentation

Late Effects of Cancer Treatment: Endocrine Effects

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Late Effects of Cancer Treatment: Endocrine Effects Thyroid Dysfunction Adrenal Insufficiency Gonadal Toxicity Growth Hormone Deficiency

  2. Objectives The learner will be able to: • Describe the pathophysiology of endocrine dysfunction in patients due to cancer treatment. • Describe the manifestation, symptoms, and diagnostic workup of endocrine dysfunction in patients due to cancer treatment.

  3. Problem • Most common late effects are endocrine. • Highest rates in adult survivors of pediatric cancer • Up to 40% of cancer survivors • Toxic treatment: • Total dose received • Duration of exposure • Interval since the completion of therapy Stava, 2007

  4. Causes • Tumor invasion to hypothalamus region • Radiation therapy • Chemotherapy • Blood and marrow transplant • Pretreatment comorbidities Hypothalamus ↓ Pituitary • National Cancer Institute (http://www.cancer.gov)

  5. Pathophysiology Thyroid ↓ ↓ Triidodthyronine (T3) ↓ Thyroxin (T4) ↓ Hypothyroidism Thyroid Impairment Hypothalamus ↓ Pituitary ↓ Growth Hormone ↓ Delayed Growth and Development Testis and Ovaries ↓ ↓ Testosterone ↓ Estrogen ↓ Progesterone ↓ Ovarian Failure Early menopause Azoospermia Adrenal Glands ↓ ↓ Cortisol ↓ Aldosterone ↓ Adrenal Insufficiency

  6. Thyroid Dysfunction:Hypothalamus-Pituitary-Thyroid Axis • Subclinical hypothyroidism/thyroid impairment—most common – ↑ thyroid stimulating hormone (TSH) with normal T4 and T3 • Overt hypothyroidism – ↑ TSH with ↓T4 and/or T3 • Symptoms • Apathetic/sluggishRetarded bone age/short stature • Bradycardia ↓ growth rate • Constipation Delayed puberty • Menstrual irregularity  Infertility/spontaneous abortion

  7. Thyroid Dysfunction:Hypothalamus-Pituitary-Thyroid Axis • Screen with thyrotropin releasing hormone (TRH) stimulation test. • Thyroid ultrasound—Nodules/irregularity • Thyroid replacement therapy: Levothyroxine

  8. Secondary Adrenal Insufficiency:Hypothalamus-Pituitary-Adrenal Axis • Many chemotherapy and radiation regimens utilize glucocorticoids • Symptoms • Fatigue and weakness • Anorexia and weight loss • Abdominal pain • Nausea and vomiting • Male infertility • Adrenal crisis (critical cortisol levels) • Hypotension • Hypoglycemia

  9. Secondary Adrenal Insufficiency:Hypothalamus-Pituitary-Adrenal Axis • Lab testing • ACTH (serum) = < 9 • Cortisol (serum before 8 am); insufficiency = < 18 • Cortisol stimulation test • Treatment • Steroid 5 mg, 10 mg, 20 mg • If mineralocorticoid deficiency: • Low aldosterone • Also use fludrocortisone 0.05–0.2 mg/day oral in am.

  10. Gonadal Toxicity: Ovarian FailureHypothalamus-Pituitary-Gonadal Axis • Damage to oocytes and follicle support • Signs: • ↑ follicle stimulating hormone (FSH) Hot flashes • ↑ luteinizing hormone (LH)  Sleep/mood disturbance • ↓ estradiol  Musculoskeletal pain • Amenorrhea  Painful intercourse • Screening: • FSH • LH • Estradiol • Treatment: • Precancer treatment fertility counseling • Estrogen and cyclic progestin

  11. Gonadal Toxicity: Early Menopause/Infertility Hypothalamus-Pituitary-Gonadal Axis • Risks without treatment: • Early and extensive osteoporosis • Cardiovascular disease • Early dementia • Treatment • No menstruation post-treatment; consider hormone replacement therapy (HRT) • Pretreatment fertility counseling

  12. Gonadal Toxicity: Azoospermia/InfertilityHypothalamus-Pituitary-Gonadal Axis • Germinal epithelium responsible for spermatogenesis • Lydig cells responsible for testosterone production • Screen • Testosterone levels • Semen analysis • Treatment • Offer pretreatment sperm banking if treatment intensity is thought to produce sterility. • Testosterone gel or injections

  13. Growth Hormone Deficiency:Hypothalamus-Pituitary-Growth Hormone Axis • Deregulation of growth hormone (GH) • Signs • Short stature Delayed tooth development • Decreased growth velocity  Delayed onset of puberty • Increased fat around the waist • Screening post-treatment • Growth charts • Growth velocity • GH levels • If deficiency, follow with: • Provocation tests/GH stimulation test • Bone age tests. • Treatment • GH injections

  14. Nursing Implications • Endocrine late effects from cancer treatment can resolve or be permanent. • Understanding your patients’ history with cancer, including treatment and medical history, is key. • Adherence to follow-up screening and reporting of symptoms is important. • Endocrine dysfunction affects patients’ physical, emotional, behavioral, and social functioning.

  15. References Chemaitilly, W., & Sklar, C. (2010). Endocrine complications in long-term survivors of childhood cancers. Endocrine-Related Cancer, 17, R141R159. Stava, C.J., Jimenez, C., & Vassilopoulou-Sellin, R. (2007). Endocrine sequelae of cancer and cancer treatments. Journal of Cancer Survivorship, 1, 261274. Tauchmanovά, L., Selleri, C., De Rosa, G., Pagano, L., Orio, F., Lombardi, G., … Colao, A. (2002). High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer, 95, 10761084.

More Related